FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutical industry, namely to compositions showing anti-cancer activity, containing bendamustine, charged cyclopolysaccharide and a stabilising agent having a charge opposite that of cyclopolysaccharide, which is specified in low-molecular protamine or polyethylene imine 2000 conjugated with PEG 8000.
EFFECT: group of inventions provides improving stability of the bendamustine compositions.
8 cl, 31 ex, 18 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BENDAMUSTINE AND CYCLOPOLYSACCHARIDE COMPOSITIONS | 2010 |
|
RU2734236C2 |
| BENDAMUSTINE AND CYCLOPOLISACCHARIDE COMPOSITION | 2011 |
|
RU2647368C2 |
| CABAZITAXEL COMPOSITION | 2013 |
|
RU2678772C2 |
| COMPOSITIONS CONTAINING POLYSACCHARIDE MATRIX FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS | 2017 |
|
RU2748261C2 |
| LIPOSOME HAVING INNER AQUEOUS PHASE AND CONTAINING SULPHOBUTYL ESTER CYCLODEXTRIN SALT | 2010 |
|
RU2575793C2 |
| COMPOSITION OF BCL-2 INHIBITOR BASED ON CYCLODEXTRIN | 2019 |
|
RU2804366C2 |
| PHARMACEUTICAL COMPOSITION IN FORM OF LYOPHILISATE WITH COMPLEXANT FOR PREPARATION OF SOLUTION FOR PARENTERAL APPLICATION AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2545902C1 |
| COMPOUND ON BASIS OF ARIPIPRAZOLE COMPLEX | 2003 |
|
RU2342931C2 |
| LYOPHILISED PREPARATION OF CYTOTOXIC DIPEPTIDES | 2012 |
|
RU2597154C2 |
| ANAESTHETIC COMPOSITION | 2011 |
|
RU2574022C2 |
